Clinical Trials Logo
  1. Home
  2. Schwannoma
  3. NCT03580850

MRI Scan and Intra-labyrinthine Schwannoma

Schwannoma Clinical Trial

Official title:
INTEREST OF INTRAVENOUS INJECTION OF GADOLINIUM IN EXPLORATION INTRA-LABYRINTHINE SCHWANNOMA IN MRI 3 TESLAS

Clinical Trial Summary

Evaluate the interest of gadolinium for the positive and topographic diagnosis of intra-labyrinthine schwannoma, comparing T1 sequence acquired after gadolinium injection to a sequence of fast imaging type employing steady state acquisition (FIESTA-C)

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03580850
Study type Observational
Source University Hospital, Strasbourg, France
Contact Francis VEILLON, MD, PhD
Phone 33 3 88 12 78 65
Email Francis.veillon@chru-strasbourg.fr
Status Recruiting
Phase
Start date February 2, 2018
Completion date February 2019
View Details
See also
  Status Clinical Trial Phase
Completed NCT01347307 - Stereotactic Body Radiotherapy for Spine Tumors N/A
Completed NCT00603694 - Hippocampal Radiation Exposure and Memory N/A
Recruiting NCT04712214 - Use of Non-invasive Optical Analysis in Neurosurgery N/A
Recruiting NCT05139277 - Evaluation of the CONVIVO System N/A
Completed NCT01951365 - Assessment of Volumetric Growth Rates of Spinal Intradural Extramedullary Schwannoma N/A
Recruiting NCT05576103 - Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients
Recruiting NCT04417868 - Evolution of Cochleovestibular Schwannomas
Recruiting NCT06421805 - Establishing Prospective Mediastinal Tumor Database of PUMCH
Recruiting NCT05254197 - SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)
Recruiting NCT04278118 - Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study N/A